Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (31-40 of 303) with videos related to

Pageof 31
Sort By:
Journal of Leukocyte Biology|March 29, 2008
S-phase entry leads to cell death in circulating T cells from HIV-infected personsScott F Sieg, Douglas A Bazdar, Michael M Lederman
Pathogens & Immunity|September 5, 2017
CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4<sup>+</sup> T CellsMichael L Freeman, Stephen R Morris, Michael M Lederman
Blood|September 28, 2013
Response: Maraviroc intensification and microbial translocationPeter W Hunt, Michael M Lederman, Steven G Deeks
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Reply to Chen et alNicholas T Funderburg, Carey L Shive, Michael M Lederman
JAMA|August 15, 2006
Biology of CCR5 and its role in HIV infection and treatmentMichael M Lederman, Adam Penn-Nicholson, Michael Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4Zhimin Feng, George R Dubyak, Michael M Lederman, et al.
AIDS (London, England)|October 18, 2008
Pulmonary arterial hypertension and its association with HIV infection: an overviewMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
AIDS (London, England)|October 18, 2008
Editors' perspective and conclusionsMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
AIDS (London, England)|July 17, 2007
A new approach for 'deep salvage' trials in advanced HIV infectionMichael M Lederman, Veronica Miller, Ian Weller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2012
Drug-resistant virus has reduced ability to induce immune activationRui Wang, Ronald J Bosch, Constance A Benson, et al.
Pageof 31

Showing results (31-40 of 303) with videos related to

Sort By:
Pageof 31
Journal of Leukocyte Biology|March 29, 2008
S-phase entry leads to cell death in circulating T cells from HIV-infected personsScott F Sieg, Douglas A Bazdar, Michael M Lederman
Pathogens & Immunity|September 5, 2017
CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4<sup>+</sup> T CellsMichael L Freeman, Stephen R Morris, Michael M Lederman
Blood|September 28, 2013
Response: Maraviroc intensification and microbial translocationPeter W Hunt, Michael M Lederman, Steven G Deeks
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2023
Reply to Chen et alNicholas T Funderburg, Carey L Shive, Michael M Lederman
JAMA|August 15, 2006
Biology of CCR5 and its role in HIV infection and treatmentMichael M Lederman, Adam Penn-Nicholson, Michael Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4Zhimin Feng, George R Dubyak, Michael M Lederman, et al.
AIDS (London, England)|October 18, 2008
Pulmonary arterial hypertension and its association with HIV infection: an overviewMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
AIDS (London, England)|October 18, 2008
Editors' perspective and conclusionsMichael M Lederman, Daniel Sereni, Gérald Simonneau, et al.
AIDS (London, England)|July 17, 2007
A new approach for 'deep salvage' trials in advanced HIV infectionMichael M Lederman, Veronica Miller, Ian Weller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2012
Drug-resistant virus has reduced ability to induce immune activationRui Wang, Ronald J Bosch, Constance A Benson, et al.
Pageof 31